Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: An individual patient based meta-analysis of two controlled trials

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 252-259

  Bendtsen, Flemming ^a   D'Amico, Gennaro ^b   Rusch, Ea ^a   De Franchis, Roberto ^c   Andersen, Per Kragh ^a   Lebrec, Didier ^d   Thabut, Dominique ^e   Bosch, Jaime ^f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute variceal bleeding; Factor rVIIa; Meta analysis; Outcome; Treatment

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TERLIPRESSIN; VASOACTIVE AGENT; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLOOD TRANSFUSION; BRAIN INFARCTION; CHILD PUGH SCORE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; DRUG SAFETY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTROINTESTINAL ENDOSCOPY; HIGH RISK PATIENT; HUMAN; LIGATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH VARICES; STOMACH VARICES BLEEDING; TREATMENT DURATION; TREATMENT OUTCOME; ACUTE DISEASE; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ACUTE DISEASE; ADULT; AGED; ESOPHAGEAL AND GASTRIC VARICES; FACTOR VIIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 84904735590     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.03.035     Document Type: Article

References (21)

1. D.Y. Graham, and J.L. Smith The course of patients after variceal hemorrhage Gastroenterology 80 1981 800 809
2. G. D'Amico, and R. De Franchis Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators Hepatology 38 2003 599 612
3. L. Hobolth, A. Krag, and F. Bendtsen The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5 Liver Int 30 2010 455 462
4. R. Banares, A. Albillos, D. Rincon, S. Alonso, M. Gonzalez, and L. Ruiz-del-Arbol et al. Endoscopic treatment vs. endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis Hepatology 35 2002 609 615
5. F. Bendtsen, A. Krag, and S. Moller Treatment of acute variceal bleeding Dig Liver Dis 40 2008 328 336
6. J.C. Garcia-Pagan, K. Caca, C. Bureau, W. Laleman, B. Appenrodt, and A. Luca et al. Early use of TIPS in patients with cirrhosis and variceal bleeding N Engl J Med 362 2010 2370 2379
7. E. Ejlersen, T. Melsen, J. Ingerslev, R.B. Andreasen, and H. Vilstrup Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices Scand J Gastroenterol 36 2001 1081 1085
8. J. Bosch, D. Thabut, F. Bendtsen, G. D'Amico, A. Albillos, and A.J. Gonzalez et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial Gastroenterology 127 2004 1123 1130
9. J. Bosch, D. Thabut, A. Albillos, N. Carbonell, J. Spicak, and J. Massard et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial Hepatology 47 2008 1604 1614
10. C. Villanueva, J. Ortiz, M. Sabat, A. Gallego, X. Torras, and G. Soriano et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial Hepatology 30 1999 384 389
11. G. D'Amico, V. Criscuoli, D. Fili, F. Mocciaro, and L. Pagliaro Meta-analysis of trials for variceal bleeding Hepatology 36 2002 1023 1024
12. M. Wells, N. Chande, P. Adams, M. Beaton, M. Levstik, and E. Boyce et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds Aliment Pharmacol Ther 35 2012 1267 1278
13. K. Soares-Weiser, M. Brezis, R. Tur-Kaspa, and L. Leibovici Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding Cochrane Database Syst Rev 2002 CD002907
14. C. Villanueva, A. Colomo, A. Bosch, M. Concepcion, M. Hernandez-Gea, and C. Aracil et al. Treatment strategies in upper gastrointestinal bleeding N Engl J Med 368 2013 11 21
15. R. De Franchis Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 43 2005 167 176
16. De. Franchis Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
17. D. Thabut, G. D'Amico, P. Tan, F.R. De, S. Fabricius, and D. Lebrec et al. Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population J Hepatol 53 2010 1029 1034
18. M. Hoffman, D.M. Monroe III, and H.R. Roberts Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII Blood Coagul Fibrinolysis 9 1998 S61 S65
19. D.E. Bernstein, L. Jeffers, E. Erhardtsen, K.R. Reddy, S. Glazer, and P. Squiban et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study Gastroenterology 113 1997 1930 1937
20. A. Avgerinos, and A. Armonis Balloon tamponade technique and efficacy in variceal haemorrhage Scand J Gastroenterol Suppl 207 1994 11 16
21. V. Yank, V. Tuohy, A.C. Logan, D.M. Bravata, K. Staudenmayer, and R. Eisenhut et al. Systematic review: benefits and harms of in-hospital use of recombinant Factor VIIa for off-label indications Ann Intern Med 154 2011 529 540